IL-EVOTIX
2.11.2021 10:02:06 CET | Business Wire | Press release
Every year over 5,000 people are killed in workplace accidents in the US and EU – a number that’s risen in the US over the last ten years1 - and blue-collar workers in the US are five times as likely to have accidents as their white-collar counterparts2 .
Evotix, an ESG business, formerly known as SHE Software and a world leader in environmental, health, safety and well-being software (EHS), announces today its mission to help organizations reduce these numbers through its investment in new staff, software, support and training services.
The business’ proposition is focussed on giving its clients ‘the confidence to transform’. For many organizations, changing the way they handle health and safety can be daunting because they don’t want to uproot established practices even if they are based on out-of-date processes and technologies. Evotix has the in-depth expertise in the latest technologies, especially those that improve and simplify the user experience, that enables organizations to implement the changes they – and their employees – need to make EHS simpler and safer.
Matthew Elson, CEO of Evotix, explains, “People, especially those that are less advantaged, have the right to work in a safer environment. Our business already helps protect the safety of over 3,000,000 employees worldwide and we’re determined to protect many, many more in the years to come.”
“Too many employees suffer workplace accidents or endure workplace related physical and mental health problems, causing issues not only for those individuals but for businesses and wider society. Many of these unfortunate situations would be avoidable if health and safety were embedded in the way the organization truly functions, supported by software featuring the latest user-friendly technologies. Engaging employees on safety issues needs to be simple, sustainable and tailored for the need of each individual organization and that’s what Evotix has been built to offer.”
“The introduction of the Evotix name is just one step on our journey. The SHE Software name has served us well during our early years, but we wanted a name that was both memorable and reflects our vision and evolved proposition. The Evotix name is a conflation of the key qualities that make us special – evolutionary technology, innovation and experience.”
Based in Chicago and London, over the past five years Evotix has grown by over 40% every year and now has over 130 staff across the US, Europe and Asia-Pacific. In the last two years the company has experienced its fastest ever growth and major customers include: GlaxoSmithKline, New Balance, Citrix and University of Cambridge.
SOLUTIONS FOR TOMORROW
Evotix focusses on promoting workplace health and safety by providing innovative and engaging technology that gets embedded in the everyday flow of activity.
Evotix provides a comprehensive solution covering all aspects of health and safety management.
The solution is online and mobile-first designed to be used quickly and easily on-the-spot. With Evotix, incidents can be reported and shared within minutes, actions can be tracked to completion and underlying trends can be analysed.
Understanding documents on a mobile phone can be challenging: many organizations have a percentage of their workforce who are illiterate. Evotix employs microlearning video and quizzes in the field to engage employees in understanding risk and following defined working methods.
Every organization is different so the software can be easily tailored and adapted as requirements evolve. Evotix is continually adding new innovation as technology evolves.
Matthew continues, “Our approach helps organizations and employees alike. For organizations, accidents and incidents are expensive, with direct costs including lost hours, damage, disruption and claims, and indirect costs including the impact on morale, reputation, stress and management distraction. “
“We believe employees deserve better. The risks associated with workplace accidents fall disproportionately on the most disadvantaged in society - gig economy workers, casual labourers. An organization that prioritises risk reduction for all its staff will perform better financially, operationally and reputationally. That’s where we are here to help.”
Dawn Hemmings at Citrix says, “I’ve partnered with Evotix for over five years at three different organisations. I have always valued them as a partner that cares as passionately about improving workplace safety as I do. That’s why, when I joined Citrix, one of my first actions was to call Evotix. We know that their vision to make EHS simpler, more intuitive and more engaging is aligned with ours and they have the capabilities and plans to make that vision a reality.”
ABOUT EVOTIX
Evotix is a global ESG technology company transforming the way employees engage in workplace health and safety. Its market leading solution, Assure, is used by more than 400 customers across a wide range of industries including manufacturing, food & drink, construction, utility services, transport & logistics, municipalities, healthcare, education and housing.
Customers include GlaxoSmithKline, New Balance, Citrix, Finsbury Foods, Eddie Stobart, Network Rail, Wacker Neuson, Euro Car Parts and University of Cambridge.
Evotix’s intuitive, mobile first application fosters worker participation, guiding frontline activities while capturing rich data to help prioritise safety and operational improvements and ensure compliance. Ease of deployment and resulting swift customer impact drive Evotix’s rapid multi-year growth.
Evotix has offices in Chicago, London, Manchester, Glasgow and Melbourne, and is backed by significant investors including Mercia Asset Management and Frog Capital.
1
Eurostat: Accidents at work; US Bureau of Labor Statistics: Fatal occupational injuries
2
US Bureau of Labor Statistics: Fatal occupational injuries
View source version on businesswire.com: https://www.businesswire.com/news/home/20211102005108/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Vertex to Acquire Crinetics Pharmaceuticals6.7.2026 22:04:00 CEST | Press release
- Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex’s portfolio - - PALSONIFY®, Crinetics’ recently launched, first and only, once-daily oral therapy for adults with acromegaly has demonstrated strong and growing early uptake - - Atumelnant, a once-daily oral adrenocorticotropic hormone (ACTH) receptor antagonist in Phase 3 development for congenital adrenal hyperplasia (CAH), has shown unique and transformative potential to both normalize androgen levels and enable management of patients with physiologic levels of glucocorticoids, the true goal of CAH management; atumelnant has also demonstrated therapeutic potential in patients with Cushing’s syndrome - - Acquisition adds to Vertex’s innovation pipeline, accelerates Vertex’s revenue growth and enhances long-term earnings profile - - Vertex to host investor call today, July 6 at 4:30 p.m. ET - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and C
Ciauru Wins the Second Edition of the Reply AI Music Contest, the International Competition Dedicated to Experimentation Across AI, Music and Live Performance6.7.2026 20:30:00 CEST | Press release
The winner was announced on the Kappa FuturFestival stage, following the performances of the five finalists selected by the international jury.German duo PARAFRAME & Avis Vox received the special Reply AI Studios Grand Prix award. The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706007611/en/ The second edition of the Reply AI Music Contest, the international competition created by Reply to explore new forms of expression combining artificial intelligence, music and live performance, concluded with the announcement of the winner on the Nova Stage powered by Reply during Kappa FuturFestival First place went to Ciauru, the stag
Rimini Street to Report Second Quarter 2026 Financial Results on July 30, 20266.7.2026 15:00:00 CEST | Press release
Rimini Street, Inc. (Nasdaq: RMNI), the Software Support and Agentic AI ERP Company™ and the leading third-party support provider for Oracle, SAP and VMware software, today announced it will report earnings after market close on July 30, 2026. The company will host a conference call and webcast on that date to discuss the second quarter 2026 results and the second half 2026 outlook at 5:00 p.m. Eastern / 2:00 p.m. Pacific time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260706560476/en/ Rimini Street to Report Second Quarter 2026 Financial Results on July 30, 2026 A live webcast of the event will be available on Rimini Street’s Investor Relations site via the Rimini Street IR events link and directly via the webcast link. Dial-in participants can access the conference by dialing 1-800-836-8184. A replay of the webcast will be available for one year following the event. About Rimini Street, Inc. Rimini Street, Inc. (Nasda
Orion and Shilpa Medicare Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe6.7.2026 15:00:00 CEST | Press release
Shilpa Medicare Limited announced that its wholly owned subsidiary, Shilpa Biologicals Private Limited, has entered into a co-development and supply agreement with Orion Corporation for intravenous (IV) nivolumab biosimilar referencing one of the world’s most widely used cancer immunotherapies to widen patient access across Europe. Nivolumab helped usher in the era of immuno-oncology, transforming the outlook for patients with cancers such as melanoma and lung cancer. As the originator approaches loss of exclusivity in Europe, this partnership aims to put a high-quality, EU-GMP-manufactured nivolumab biosimilar within reach of more patients, reducing healthcare burden. In 2025, Nivolumab recorded sales of approximately USD4.1 billion (Source: IQVIA/IMS) Europe — underscoring the scale of the opportunity. Under the agreement, Orion will hold the exclusive rights to register, market, distribute and sell the nivolumab biosimilar across Europe. Shilpa Biologicals will lead product developm
No-Loss Trading Platform UpsideOnly Surpasses 100,000 Users Within Weeks of Launch6.7.2026 14:48:00 CEST | Press release
Rapid growth shows strong demand for a new trading model where users can make market predictions without risking their own capital Perpetuals.com Ltd (Nasdaq: PDC), today announced that UpsideOnly, its risk-free trading and market prediction platform, has seen a surge in new user sign-ups, surpassing the important milestone of 100,000 traders within weeks of its launch on May 19. UpsideOnly lets users make predictions about where global equity, commodity, forex, and crypto markets are heading without ever placing a real trade themselves. Perpetuals uses its own capital to trade on the strongest signals identified by its proprietary AI. If those trades win, Perpetuals shares the profits with the users who helped generate the signal. If the trade doesn’t make money, users lose nothing. Reaching 100,000 users so quickly after launching is a reflection of the enormous demand for a platform that flips the traditional retail trading model on its head, with early platform data showing strong
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
